Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents

Surgical Oncology Clinics of North America

Volumn 12, Issue 3, 2003, Pages 689-701

  Sticca, Robert P ^a   Dach, Brian W ^b  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GREENVILLE HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOMYCIN C; OXALIPLATIN;

ACIDITY; AEROBIC METABOLISM; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOMATOUS PERITONITIS; CELL DEATH; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HYPERTHERMIC THERAPY; INHIBITION KINETICS; MICROENVIRONMENT; MORBIDITY; MORTALITY; MULTIMODALITY CANCER THERAPY; OXIDATIVE STRESS; PATIENT MONITORING; PERITONEUM CANCER; PERITONEUM PSEUDOMYXOMA; PH MEASUREMENT; RECURRENCE RISK; REVIEW;

EID: 0041743202     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(03)00029-2     Document Type: Review

References (50)

1. Hornback N. Historical aspects of hyperthermia in cancer therapy. Radiol Clin North Am 1989;27(3):481-8.
2. Hippocrates. Aphorisms. Translated by Francis Adams. The internet classics archive by Daniel C. Stevenson, Web Atomics.
3. Busch W. Uber den Einfluss Weichen Heftigere Erysipelen Zuweilen auf Orgisierte Neubildungen Ausuken Verhandl, Rheinisch-Westfael. Akad Wiss Nat Lng Wirtschaftswiss Vortr 1866;23:28-30.
4. Bruns P. Die Heilwirkung des Erysipels auf Gerschwulste. Beitr Klin Chir 1887;3:443-66.
5. Fehleisen F. Aetcologie des Erisypels. Berlin: Verlag Von Theodor Fischer's Medicinisher Buchlandlung; 1883.
6. Gerster AG, Hartley F. Sarcoma of the femur without recurrence five years after amputation through the trochanter minor. NY Med J 1892;55:641.
7. Vidal E. Cancer et traumatism. In: Alcan F, editor. Assoc franc de chirurgie. Paris: 1907.
8. Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas - with a report of ten original cases. Am J Med Sci 1893;105:487-511.
9. Byrne J. A digest of 20 years' experience in the treatment of cancer of the uterus by galvanocautery. Am J Obstet Gynecol 1899;22:1052.
10. Gottschalk S. Zur Behandlung des Ulcerirenden Inoperablen Cervixcarcinoms. Zentralblatt Gynak. 1899;79-80.
11. Mayo WJ. Grafting and traumatic dissemination of carcinoma in the course of operations for malignant disease. JAMA 1913;60:512.
12. Mayo WJ. The cancer problem. Lancet 1915;35:339.
13. Percy JF. Heat in the treatment of carcinomas of the uterus. Surg Gynecol Obstet 1916;22:77-9.
14. Goetze O. Oritliche Homogene Uberwarmung Gesunder und Krunker Glied Massen. Dtsch Z Chir 1932;234:577.
15. Warren SL. Preliminary study of the effect of artificial fever upon hopeless tumor cases. Am J Roentgenol 1935;33:75-87.
16. Kirsch R, Schmidt D. Erste Experimentelle and Klinishe Erfahrungen mit der Ganzkorper-Extrem-Hyperthermie. In: Doerr F, Linder F, Wagner G, editors. Aktuelle Problem aus dem Gebiet der Cancerlogie. Heidelberg: Springer-Verlag; 1966. p. 53-70.
17. Cavaliere R, Ciocatto EC, Giovanella BP, Heidelberger C, Johnson RO, Margottini M, et al. Selective heat sensitivity of cancer cells, biochemical and clinical studies. Cancer 1967;20(9):1351-81.
18. Loeb L. Uber Transplantation von Tumoren. Virchow's Arch Pathol Anat 1903;172:345-68.
19. Jensen CO. Experimentelle Untersuchungen uber Krebs bei Mausen. Zentralblat Bakteriol 1903;34:28-122.
20. Haaland M. Contributions to the study of the development of sarcomas under experimental conditions. Imp Cancer Res Fund Rep 1908;175-261.
21. Lambert RA. Demonstration of the greater sensitivity to heat of sarcoma cells as compared with actively proliferating connective-tissue cells. JAMA 1912;59:2147-8.
22. Vollmar H. Uber den Einfluss der Temperatur auf Normales Gewebe und auf Tumorgewebe. Z Krebsforsch 1941;51:71-99.
23. Chen TT, Heidelberger C. Quantitative studies on the malignant transformation of mouse prostate cells by carcinogenic hydrocarbons in vitro. Int J Cancer 1969;4:166-78.
24. Selawry OS, Goldstein MN, McCormick T. Hyperthermia in tissue cultured-cells of malignant origin. Cancer Res 1957;17:785-91.
25. Kase KR, Hahn GM. Differential heat response of normal and transformed human cells in tissue culture. Nature 1975;255:228-30.
26. Kase KR, Hahn GM. Comparison of some response to hyperthermia by normal human diploid cells and neoplastic cells from the same origin. Eur J Cancer 1976;12:481-91.
27. Levine EM, Robbins EB. Differential temperature sensitivity of normal and cancer cells in culture. J Cell Physiol 1970;76:373-80.
28. Giovanella BC, Stehlin JS, Morgan AC. Selective lethal effect of supranormal temperatures on human neoplastic cells. Cancer Res 1976;36:3944-50.
29. Rohdenburg GL, Prime F. Effect of combined radiation and heat on neoplasms. Arch Surg 1921;2:116-29.
30. Westermark H. The effect of heat upon rat tumors. Skand Arch Physiol 1927;52:257-322.
31. Overgaard K, Overgaard J. Investigations on the possibility of a thermic tumour therapy - 1. Short-wave treatment of a transplanted isologous mouse mammary carcinoma. Eur J Cancer 1972;8:65-78.
32. Overgaard K, Overgaard J. Pathology of heat damage. Proc Int Symp on cancer therapy by hyperthermia and radiation. Washington, DC: 1975; p. 115-27.
33. Overgaard J. Ultrastructure of a murine mammary carcinoma exposed to hyperthermia in vivo. Cancer Res 1976;36:983-95.
34. Overgaard J. Effect of hyperthermia on malignant cells in-vivo, a review and hypothesis. Cancer 1977;39:2637-46.
35. Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 1984;44:605-12.
36. Storm FC. Clinical hyperthermia and chemotherapy. Radiol Clin North Am 1989;27(3):621-7.
37. Hahn GM, Braun J, Har-Kedar I. Thermochemotherapy: synergism between hyperthermia and Adriamysin (or bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci USA 1975;172:937-40.
38. Hahn GM, Shiu EC. Effect of pH and elevated temperatures on the cytotoxicity of some therapeutic agents on Chinese hamster cells in vitro. Cancer Res 1983;43:5789-91.
39. Bull JMC. An update on the anticancer effects of a combination of chemotherapy and hyperthermia. Cancer Res 1984;44(Suppl):4853-6.
40. Stewart JR, Bagshaw MA, Corry PM, et al. Hyperthermia as a treatment of cancer. Cancer Treat Symp 1984;1:135.
41. Barlogie B, Corry PM, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlordiammineplatinum(II) and Mitomycin C. Cancer Res 1980;40:1165-8.
42. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FAN. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88:458-63.
43. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727-31.
44. Los G, van Vugt MJH, den Engelse L, Pinedo HM. Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA. Biochem Pharmacol 1993;46(7):1229-37.
45. Los G, van Vugt MJH, Pinedo HM. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 1994;69(2):235-41.
46. Los G, Sminia P, Wondergem J, Mutsaers PHA, Havemen J, Huinink DB, et al. Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur J Cancer 1991;27(4):472-7.
47. Carter SK. Adiramycin - a review. J Natl Cancer Inst 1975;55:1265-74.
48. Ozols RF, Locker GY, Doroshow JH. Pharmacokinetics of adriamycin and tissue penetration in murine ovarian carcinoma. Cancer Res 1979;39:3209-13.
49. Jacquet P, Averbach A, Stuart OA, Chang D, Sugarbaker PH. Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol 1998;41:147-54.
50. Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El OA, et al. Heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol 2002;13(2):267-72.